1. Chughtai B, Forde JC, Thomas DDM et al (2016) Benign prostatic hyperplasia. Nat Rev Dis Prim 2:1–15. https://doi.org/10.1038/nrdp.2016.31
2. Benign Prostatic Hyperplasia (BPH) Guideline—American Urological Association. https://www.auanet.org/guidelines/benign-prostatic-hyperplasia-(bph)-guideline#x8218. Accessed 2 Apr 2020
3. Gravas S, Cornu JN, Gacci M et al (2020) EAU Guidelines: Management of Non-neurogenic Male LUTS, incl. Benign prostatic obstruction (BPO). https://uroweb.org/guideline/treatment-of-non-neurogenic-male-luts/. Accessed 17 Apr 2020
4. Van Asseldonk B, Barkin J, Elterman DS (2015) Medical therapy for benign prostatic hyperplasia: a review. Can J Urol 22(Suppl 1):7–17
5. Ahyai SA, Gilling P, Kaplan SA et al (2010) Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 58:384–397